Furthermore, PPARγ has specifically been linked to GM-CSF function based on the finding that patients with (e.g., PAP) often have autoantibodies to GM-CSF or mutations in the receptor for GM-CSF, which leads to dysregulated surfactant metabolism by alveolar macrophages. This evidence concerns the gene PPARG and pulmonary alveolar proteinosis.